Nomura H, Shimizume R, Ikegaya Y
Curr Top Behav Neurosci. 2021; 59:329-353.
PMID: 34435342
DOI: 10.1007/7854_2021_253.
Wong K, Roy J, Fung M, Heng B, Zhang C, Lim L
Aging Dis. 2020; 11(5):1291-1316.
PMID: 33014538
PMC: 7505271.
DOI: 10.14336/AD.2019.1125.
Annamalai B, Varman D, Horton R, Daws L, Jayanthi L, Ramamoorthy S
ACS Chem Neurosci. 2020; 11(3):466-476.
PMID: 31916747
PMC: 7004881.
DOI: 10.1021/acschemneuro.9b00664.
Chauveau F, De Job E, Poly-Thomasson B, Cavroy R, Thomasson J, Fromage D
CNS Neurosci Ther. 2019; 25(8):832-841.
PMID: 31094061
PMC: 6630007.
DOI: 10.1111/cns.13113.
Hackelberg S, Oliver D
Sci Rep. 2018; 8(1):12987.
PMID: 30154490
PMC: 6113233.
DOI: 10.1038/s41598-018-31322-8.
An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels.
Zhou X, Li Y, Shi X, Ma C
Am J Transl Res. 2016; 8(2):246-69.
PMID: 27158324
PMC: 4846881.
Impaired Functional Connectivity in the Prefrontal Cortex: A Mechanism for Chronic Stress-Induced Neuropsychiatric Disorders.
Negron-Oyarzo I, Aboitiz F, Fuentealba P
Neural Plast. 2016; 2016:7539065.
PMID: 26904302
PMC: 4745936.
DOI: 10.1155/2016/7539065.
Use of Push-Pull Superfusion Technique for Identifying Neurotransmitters Involved in Brain Functions: Achievements and Perspectives.
Kraus M, Philippu A
Curr Neuropharmacol. 2015; 13(6):819-29.
PMID: 26630960
PMC: 4759321.
DOI: 10.2174/1570159x13666150722233149.
3-iodothyroacetic acid, a metabolite of thyroid hormone, induces itch and reduces threshold to noxious and to painful heat stimuli in mice.
Laurino A, De Siena G, Resta F, Masi A, Musilli C, Zucchi R
Br J Pharmacol. 2014; 172(7):1859-68.
PMID: 25439265
PMC: 4376462.
DOI: 10.1111/bph.13032.
Histamine mediates behavioural and metabolic effects of 3-iodothyroacetic acid, an endogenous end product of thyroid hormone metabolism.
Musilli C, De Siena G, Manni M, Logli A, Landucci E, Zucchi R
Br J Pharmacol. 2014; 171(14):3476-84.
PMID: 24641572
PMC: 4105934.
DOI: 10.1111/bph.12697.
Histaminergic modulation of cholinergic release from the nucleus basalis magnocellularis into insular cortex during taste aversive memory formation.
Puron-Sierra L, Miranda M
PLoS One. 2014; 9(3):e91120.
PMID: 24625748
PMC: 3953328.
DOI: 10.1371/journal.pone.0091120.
Effect of histamine H1 and H2 receptor antagonists, microinjected into cerebellar vermis, on emotional memory consolidation in mice.
Gianlorenco A, Serafim K, Canto-de-Souza A, Mattioli R
Braz J Med Biol Res. 2014; 47(2):135-43.
PMID: 24519129
PMC: 4051186.
DOI: 10.1590/1414-431X20133429.
Low-dose thioperamide injected into the cerebellar vermis of mice immediately after exposure to the elevated plus-maze impairs their avoidance behavior on re-exposure to the apparatus.
Costa Neto J, Serafim K, Gianlorenco A, Mattioli R
Braz J Med Biol Res. 2013; 46(11):943-948.
PMID: 24270913
PMC: 3854336.
DOI: 10.1590/1414-431X20133179.
Facilitation of short-term memory by histaminergic neurons in the nucleus accumbens is independent of cholinergic and glutamatergic transmission.
Kraus M, Prast H, Philippu A
Br J Pharmacol. 2013; 170(1):214-21.
PMID: 23750549
PMC: 3764862.
DOI: 10.1111/bph.12271.
The neglected role of histamine in Alzheimer's disease.
Naddafi F, Mirshafiey A
Am J Alzheimers Dis Other Demen. 2013; 28(4):327-36.
PMID: 23677734
PMC: 10852771.
DOI: 10.1177/1533317513488925.
Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist.
Boess F, De Vry J, Erb C, Flessner T, Hendrix M, Luithle J
Psychopharmacology (Berl). 2012; 227(1):1-17.
PMID: 23241647
DOI: 10.1007/s00213-012-2933-4.
Histaminergic modulation of nonspecific plasticity of the auditory system and differential gating.
Ji W, Suga N
J Neurophysiol. 2012; 109(3):792-802.
PMID: 23136340
PMC: 3567387.
DOI: 10.1152/jn.00930.2011.
GABAergic neuron specification in the spinal cord, the cerebellum, and the cochlear nucleus.
Hori K, Hoshino M
Neural Plast. 2012; 2012:921732.
PMID: 22830054
PMC: 3395262.
DOI: 10.1155/2012/921732.
Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression.
Silva Moura D, Sultan S, Georgin-Lavialle S, Barete S, Lortholary O, Gaillard R
PLoS One. 2012; 7(6):e39468.
PMID: 22745762
PMC: 3379977.
DOI: 10.1371/journal.pone.0039468.
Circadian and wakefulness-sleep modulation of cognition in humans.
Wright K, Lowry C, LeBourgeois M
Front Mol Neurosci. 2012; 5:50.
PMID: 22529774
PMC: 3328852.
DOI: 10.3389/fnmol.2012.00050.